我院时间依赖性抗菌药物输注间隔时间不规范的原因及对策分析
x

请在关注微信后,向客服人员索取文件

篇名: 我院时间依赖性抗菌药物输注间隔时间不规范的原因及对策分析
TITLE:
摘要: 目的:为规范时间依赖性抗菌药物输注间隔时间提供参考。方法:采用横断面调查研究,随机选择2016年5月28日我院使用时间依赖性抗菌药物的住院患者336例,对其时间依赖性抗菌药物输注间隔时间进行调查和分析,发现存在的问题,分析可能的原因并提出改进措施。结果:我院使用的时间依赖性抗菌药物大部分为β-内酰胺类药物;bid给药的时间依赖性抗菌药物输注间隔时间<8 h的占84.62%;不规范间隔用药在bid给药与定点给药(q8 h或q12 h)的患者之间(68.75% vs. 4.17%),差异有统计学意义(P<0.05);不同科室和病区不规范输注间隔的发生率有较大差别。分析原因可能与医师、护士、科室及其他医疗条件等因素有关。结论:我院住院患者时间依赖性抗菌药物输注间隔时间过短,不规范情况突出,应从医师、护理人员、科室等多方加强管理、教育与培训,以保障患者用药安全、有效。
ABSTRACT: OBJECTIVE: To provide reference for standardize infusion interval time of time-dependent antibiotics. METHODS: In cross-sectional study, 336 inpatients receiving time-dependent antibiotics were randomly selected from our hospital in May 28th, 2015. The infusion interval of time-dependent antibiotics was investigated and analyzed to find out the problems, analyze the causes and put forward the improvement measures. RESULTS: Most of the time-dependent antibiotics used in our hospital are β-lactam antibiotics. 84.62% time-dependent antibiotics of the bid infusion interval was lower than 8 h; the proportion of patients with nonstandard infusion interval of bid and regalar use (q8 h or q12 h)(68.75% vs. 4.17%),with statistical significance (P<0.05). There was great difference in the incidence of nonstandard infusion interval among different departments and wards. It may be associated with physicians, nurses, departments and other medical conditions.  CONCLUSIONS: The infusion interval time of time-dependent antibiotics is too short in the inpatients of our hospital, and nonstandard infusion interval is serious; it is suggested to strengthen management, education and training from physicians, nurses and departments, so as to guarantee the safety and effectiveness of drug use.
期刊: 2017年第28卷第2期
作者: 黄娟,唐晓铃,柯昌毅,李元丽,张爱国
AUTHORS: HUANG Juan,TANG Xiaoling,KE Changyi,LI Yuanli,ZHANG Aiguo
关键字: 时间依赖性抗菌药物;间隔时间;合理用药
KEYWORDS: Time-dependent antibiotics; Interval time; Rational drug use
阅读数: 564 次
本月下载数: 14 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!